The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 09, 2019
Filed:
Mar. 24, 2015
Applicants:
Canget Bio Tekpharma, Llc, Buffalo, NY (US);
Xiang Ling, Buffalo, NY (US);
Fengzhi LI, Buffalo, NY (US);
Inventors:
Fengzhi Li, Buffalo, NY (US);
Xiang Ling, Buffalo, NY (US);
Assignee:
Canget BioTek Pharma LLC, Buffalo, NY (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 491/22 (2006.01); C07D 491/00 (2006.01); A61K 45/06 (2006.01); A61K 31/4745 (2006.01); A61P 35/00 (2006.01); A61K 9/19 (2006.01); A61K 47/02 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01); A61K 47/34 (2017.01); A61K 47/38 (2006.01); A61K 47/40 (2006.01);
U.S. Cl.
CPC ...
C07D 491/22 (2013.01); A61K 9/19 (2013.01); A61K 31/4745 (2013.01); A61K 45/06 (2013.01); A61K 47/02 (2013.01); A61K 47/10 (2013.01); A61K 47/20 (2013.01); A61K 47/34 (2013.01); A61K 47/38 (2013.01); A61K 47/40 (2013.01); A61P 35/00 (2018.01);
Abstract
Described herein, are FL118 core structure platform compounds, matter of compositions, formulation, methods and uses for treating cancer or other human diseases. Chemical modifications of the FL118 structure are employed alone or in combination with other anti-cancer agents to preclude or reverse refractory cancer phenotypes and for unique personalized cancer treatment (personalized medicine or as Obama called precision medicine) through application of a series of structural relevant individual FL118 platform-derived analogs.